Wed, February 7, 2018

Catherine Schulte Maintained (TECH) at Buy and Held Target at $39 on, Feb 7th, 2018

Catherine Schulte of Baird, Maintained "Bio-Techne Corporation" (TECH) at Buy and Held Target at $39 on, Feb 7th, 2018.

Catherine has made no other calls on TECH in the last 4 months.



There is 1 other peer that has a rating on TECH. Out of the 1 peers that are also analyzing TECH, 0 agree with Catherine's Rating of Hold.



This is the rating of the analyst that currently disagrees with Catherine


  • Daniel Arias of "Citigroup" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, October 24th, 2017